×

CellRapeutics™ Leukopak from Hidradenitis Suppurativa Donor (XS-0426-XU244)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Obtained from donors with Hidradenitis Suppurativa, this Leukopak captures the systemic immune dysregulation associated with this debilitating follicular occlusive disease. The cellular profile is characterized by elevated Th17 activity and high levels of circulating TNF-α and IL-1 producing myeloid cells. This product facilitates advanced research into the systemic inflammatory "burden" of HS and the identification of biomarkers for disease severity.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ Leukopak from Hidradenitis Suppurativa Donor
  • Cat. No.
  • XS-0426-XU244
  • Donor Age
  • Young Adult
  • Donor Health
  • Donors exhibit severe chronic follicular inflammation. The leukocyte profile is characterized by high levels of circulating inflammatory mediators and expanded Th17-associated cell populations.
  • Ethnicity
  • Diverse backgrounds available, predominantly African American cohorts.
  • Anticoagulant
  • Acid Citrate Dextrose, prioritized to protect activated effector cells and maintain the integrity of follicular-homing lymphocytes.
  • Additional Donor Information
  • Each lot features a Leukopak from donors with clinically confirmed HS. Profiles include Hurley stage and lesion distribution data, supporting research into the peripheral immune markers of chronic follicular occlusion.
  • Clinical Profile
  • Hurley staging, affected anatomical regions, and history of systemic antibiotic or biologic treatment.

Additional Information

  • Medication History
  • Available upon request. Includes records of systemic antibiotics, hormonal modulators, and exposure to biological therapies.
  • Formulation
  • Cryopreserved or Fresh options available.
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.
  • Storage
  • Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • Full Bag, Half Bag
  • Keywords
  • CellRapeutics™ Leukopak from Hidradenitis Suppurativa Donor, Leukopak, Hidradenitis Suppurativa

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Hidradenitis Suppurativa Donor (XS-0426-XU244). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.